References

  1. Allolio B, Fassnacht M. Adrenocortical Carcinoma: clinical update. J Clin Endocrinol Metab. 2006 Jun; 91(6): 2027-37. Epub 2006 Mar 21. PubMed

  2. Seccia TM, Fassina A, Nussdorfer GG, Pessina AC et al. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer. 2005 Mar; 12(1): 149-159. PubMed | Google Scholar

  3. Weingartner K, Gerharz EW, Bittinger A, Rosai J. Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Urol Int. 1995; 55(4): 232-235. PubMed | Google Scholar

  4. Funder JW, Carey RM, Mantero F, Murad MH et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 May; 101(5): 1889-1916. PubMed | Google Scholar

  5. Fassnacht M, Johanssen S, Quinkler M, Bucsky P et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009 Jan; 115(2): 243-250. PubMed | Google Scholar

  6. Chen QL, Su Z, Li YH, Ma HM et al. Clinical characteristics of adrenocortical tumors in children. J Pediatr Endocrinol Metab. 2011; 24(7-8): 535-541. PubMed | Google Scholar

  7. Pigeon B, Ryckewaert P, Massin B. Virilizing adrenal cortical tumor in children: a propos of a neonatal case. Pediatrie. 1985 Jun; 40(4): 309-312. PubMed | Google Scholar

  8. Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol. 2011 Feb; 29(6): e127-130. PubMed | Google Scholar

  9. Griffin AC, Kelz R, LiVolsi VA. Aldosterone-secreting adrenal cortical carcinoma: a case report and review of the literature. Endocr Pathol. 2014 Sep; 25(3): 344-349. PubMed | Google Scholar

  10. Drevet D, Guzelian J, Van Box Som P, Champion M et al. Malignant adrenocortical carcinoma with atypical aspect: value of tomodensitometry and magnetic resonance imaging; a propos of a case. Ann Radiol. 1996; 39(3): 126-130. PubMed | Google Scholar

  11. Mario MA, Claudia RR, Analleli ML, Pedro PG et al. A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal Carcinoma. Case Rep Endocrinol. 2015 Jun; 2015: 910984. Google Scholar

  12. Min Soo S, Sung Woo S, Sang Byung B, Yeo Joo K et al. Aldosterone-Producing Adrenocortical Carcinoma without Hypertension. Korean J Intern Med. 2012 Jun; 27(2): 221-223. PubMed | Google Scholar

  13. Kennosuke O, Takeshi H, Masaya S, Hiroyuki I et al. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report. BMC Endocrine Disorders. 2016 Jan; 16: 3. PubMed | Google Scholar

  14. Lazaro K, Adorable PW. Aldosterone-producing Adrenocortical carcinoma with co-secretion of cortisol and estradiol: case report. Journal of the Asean Federation of Endocrine Societies. 2018 Nov; 33(1): 57-62. Google Scholar

  15. Hussain S, Panteliou E, Berney DM, Carpenter R et al. Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism. Endocrinol Diabetes Metab Case Rep. 2015 Jul; 2015: 150064. PubMed | Google Scholar

  16. Baudin E, Pellegriti G, Bonnay M, Penfornis A et al. Impact of monitoring plasma 1,1 dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer. 2001 Sep; 92(6): 1385-1592. Google Scholar

  17. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery. 1992 Dec; 112(6): 963-971. PubMed | Google Scholar

  18. Fay AP, Elfiky A, Teló GH, McKay RR et al. Adrenocortical carcinoma: the management of metastatic disease. Crit Rev Oncol Hematol. 2014 Nov; 92(2): 123-132. PubMed | Google Scholar

  19. Hermsen IGC, Groenen YE, Dercksen MW, Theuws J et al. Response to radiation therapy in adrenocortical carcinoma. J Endocrinol Invest. 2010 Nov; 33(10): 712-714. PubMed | Google Scholar